Kibdelone C is a natural substance isolated from the bacterium Kibdelosporangium sp.. It is primarily investigated for its potential in cancer therapy due to its strong antitumor properties. Studies have shown its effectiveness in inhibiting the growth of various cancer cell lines, particularly colon and lung cancer, making it a promising candidate for developing new anticancer drugs. Researchers are exploring its mechanism of action, particularly its ability to interfere with cellular processes critical for tumor survival. Additionally, Kibdelone C is studied for its role in overcoming drug resistance in certain cancers, which could enhance the efficacy of existing treatments. It also exhibits antibacterial and antifungal activities, positioning it as a candidate for developing antimicrobial agents. Its unique structure makes it a key target in medicinal chemistry for designing novel therapeutic agents.